Mast cell and T cell communication; amplification and control of adaptive immunity.

Recent advances in understanding the physiological role of mast cells (MCs) point to an important regulatory role for these cells in adaptive immunity. MCs express a diverse array of molecules that can promote their interaction with T cells as well as with other immune cells. New evidence demonstrates that mast cells can directly and indirectly communicate with T cells. They can control both effector and regulatory T cell responses and their activity can in turn be modulated by these interactions. Here we briefly summarize these advances and discuss some of the major challenges in understanding the communication of MCs and T cells.

[1]  S. Balk,et al.  Kinetics of cytolytic T lymphocyte binding to target cells in suspension. , 1981, Journal of immunology.

[2]  Yukihiko Kitamura,et al.  Decrease of mast cells in w/wv mice and their increase by bone marrow transplantation. , 1978 .

[3]  Walid Beghdadi,et al.  Mast Cell-Dependent Down-Regulation of Antigen-Specific Immune Responses by Mosquito Bites1 , 2006, The Journal of Immunology.

[4]  Y. Naparstek,et al.  Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis , 2001, Scandinavian journal of clinical and laboratory investigation.

[5]  L. Bouton,et al.  Stat5 expression is critical for mast cell development and survival. , 2003, Blood.

[6]  C. Chen,et al.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.

[7]  K. Tasaka,et al.  Histamine release from beta-escin-permeabilized rat peritoneal mast cells and its inhibition by intracellular Ca2+ blockers, calmodulin inhibitors and cAMP. , 1989, Immunopharmacology.

[8]  K. Melmon,et al.  Regulatory effects of mast cells on lymphoid cells: the role of histamine type 1 receptors in the interaction between mast cells, helper T cells and natural suppressor cells. , 1986, Cellular immunology.

[9]  H. Abboud,et al.  Actions and metabolism of histamine in glomeruli and tubules of the human kidney. , 1984, Kidney international.

[10]  K. Ishizaka,et al.  Identification of gamma-E-antibodies as a carrier of reaginic activity. , 1967, Journal of immunology.

[11]  Tomoko Fujita,et al.  Type I Interferons Attenuate T Cell Activating Functions of Human Mast Cells by Decreasing TNF-α Production and OX40 Ligand Expression While Increasing IL-10 Production , 2006, Journal of Clinical Immunology.

[12]  J. Johnston,et al.  In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction , 1996, The Journal of experimental medicine.

[13]  M. Tsai,et al.  Mast cells in the development of adaptive immune responses , 2005, Nature Immunology.

[14]  D. Conrad,et al.  IL-10 Suppresses Mast Cell IgE Receptor Expression and Signaling In Vitro and In Vivo1 , 2008, The Journal of Immunology.

[15]  H. Xiong,et al.  SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. , 2008, Blood.

[16]  D. Friend,et al.  Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. , 1998, Journal of immunology.

[17]  S. Balk,et al.  Specific reversal of cytolytic T lymphocyte--target cell interaction. , 1981, Journal of supramolecular structure and cellular biochemistry.

[18]  Zhao-You Tang,et al.  Combination of peritumoral mast cells and T‐regulatory cells predicts prognosis of hepatocellular carcinoma , 2009, Cancer science.

[19]  K. Okumura,et al.  Notch signaling confers antigen-presenting cell functions on mast cells. , 2009, The Journal of allergy and clinical immunology.

[20]  J. Rivera Snake bites and bee stings: the mast cell strikes back , 2006, Nature Medicine.

[21]  G. B. West,et al.  Tissue mast cells: studies with a histamine-liberator of low toxicity (compound 48/80). , 1955, The Journal of pathology and bacteriology.

[22]  P. Wolters,et al.  Tissue‐selective mast cell reconstitution and differential lung gene expression in mast cell‐deficient KitW‐sh/KitW‐sh sash mice , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  N. Novak,et al.  Histamine and histamine intolerance. , 2007, The American journal of clinical nutrition.

[24]  S. Thakurdas,et al.  The Mast Cell-restricted Tryptase mMCP-6 Has a Critical Immunoprotective Role in Bacterial Infections* , 2007, Journal of Biological Chemistry.

[25]  J. Lohr,et al.  Regulatory T cells in the periphery , 2006, Immunological reviews.

[26]  Jingyong Zhao,et al.  Adoptive Transfer of In Vitro-Stimulated CD4+CD25+ Regulatory T Cells Increases Bacterial Clearance and Improves Survival in Polymicrobial Sepsis , 2005, The Journal of Immunology.

[27]  Baowei Su,et al.  Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells. , 2008, Biochemical and biophysical research communications.

[28]  Stephen J Galli,et al.  Mast cell–derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B , 2007, Nature Immunology.

[29]  C. Gutekunst,et al.  Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis , 2000, The Journal of experimental medicine.

[30]  D. Metcalfe,et al.  Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. , 1998, Journal of immunology.

[31]  C. Chen,et al.  Mast Cells Can Enhance Resistance to Snake and Honeybee Venoms , 2006, Science.

[32]  J. Marshall Mast-cell responses to pathogens , 2004, Nature Reviews Immunology.

[33]  J. White,et al.  Activation of basophils and mast cells for mediator release. , 1987, International archives of allergy and applied immunology.

[34]  D. Payan,et al.  R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation , 2006, Journal of Pharmacology and Experimental Therapeutics.

[35]  M. Tsai,et al.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances. , 2005, Annual review of immunology.

[36]  P. Fietta Life-or-death fate in the adaptive immune system. , 2007, Rivista di biologia.

[37]  D. Metcalfe,et al.  Mast cells in innate immunity , 2000, Immunological reviews.

[38]  C. Benoist,et al.  Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. , 2008, The American journal of pathology.

[39]  R. Noelle,et al.  Mast Cell Degranulation Breaks Peripheral Tolerance , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[40]  E. Masuda,et al.  Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406. , 2007, Toxicology and applied pharmacology.

[41]  Carlos D Ramirez,et al.  TGFβ1 induces mast cell apoptosis , 2006 .

[42]  M. Tsai,et al.  Mast Cells Enhance T Cell Activation: Importance of Mast Cell Costimulatory Molecules and Secreted TNF1 , 2006, The Journal of Immunology.

[43]  P. Conlon,et al.  IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. , 1994, Journal of immunology.

[44]  M. Colombo,et al.  CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. , 2008, Immunity.

[45]  S. Jewell,et al.  Rat peritoneal mast cells present antigen to a PPD-specific T cell line. , 1994, Cellular immunology.

[46]  R. Siegel,et al.  Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders , 2009, Current opinion in rheumatology.

[47]  W. Paul,et al.  Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores , 1989, Nature.

[48]  M. Beaven Our perception of the mast cell from Paul Ehrlich to now , 2009, European journal of immunology.

[49]  C. Tkaczyk,et al.  Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes , 1996, European journal of immunology.

[50]  T. Strom,et al.  T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. , 2009, Cancer research.

[51]  K. Austen,et al.  Mast cell mediator release as a function of cyclic AMP-dependent protein kinase activation , 1981, The Journal of experimental medicine.

[52]  David C. Gondek,et al.  Mast cells are essential intermediaries in regulatory T-cell tolerance , 2006, Nature.

[53]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[54]  E. Kölsch The genetic control of T cell‐mediated immunity against the DBA/2 mastocytoma P‐815. II. Low responsiveness in T cell‐mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response , 1975, European journal of immunology.

[55]  Melissa A Brown,et al.  Mast Cells , 2008, Annals of the New York Academy of Sciences.

[56]  D. Hoskin,et al.  Mast Cells Down-Regulate CD4+CD25+ T Regulatory Cell Suppressor Function via Histamine H1 Receptor Interaction1 , 2009, The Journal of Immunology.

[57]  C. Gutekunst,et al.  Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course 1 , 2003, The Journal of Immunology.

[58]  Lin Zhao,et al.  Induction of Adaptive T Regulatory Cells That Suppress the Allergic Response by Coimmunization of DNA and Protein Vaccines1 , 2008, The Journal of Immunology.

[59]  Y. Okayama,et al.  T Cell Proliferation by Direct Cross-Talk between OX40 Ligand on Human Mast Cells and OX40 on Human T Cells: Comparison of Gene Expression Profiles between Human Tonsillar and Lung-Cultured Mast Cells1 , 2004, The Journal of Immunology.

[60]  M. Colombo,et al.  Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. , 2009, Blood.

[61]  R. Liblau,et al.  Cell-cell cooperation at the T helper cell/mast cell immunological synapse. , 2009, Blood.

[62]  W. Leonard,et al.  Cutting Edge: CD4 T Cell-Mast Cell Interactions Alter IgE Receptor Expression and Signaling1 , 2008, The Journal of Immunology.

[63]  R. Noelle,et al.  Mast cells as regulators of adaptive immunity to tumours , 2009, Clinical and experimental immunology.

[64]  J S Gonnella,et al.  What have we learned, and where do we go from here? , 1993, Academic medicine : journal of the Association of American Medical Colleges.

[65]  Melissa A Brown,et al.  Mast cells as modulators of T‐cell responses , 2007, Immunological reviews.

[66]  J. Kinet,et al.  Emerging picture of the receptor with high affinity for IgE. , 1989, International archives of allergy and applied immunology.

[67]  Christoph Wilhelm,et al.  Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.

[68]  V. Secor,et al.  Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis , 2005, European journal of immunology.

[69]  Yuetsu Tanaka,et al.  Expression and function of OX40 ligand on human dendritic cells. , 1997, Journal of immunology.

[70]  R. Paus,et al.  Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. , 2009, Immunity.

[71]  M. Tsai,et al.  Mast cells enhance T cell activation: Importance of mast cell-derived TNF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[72]  R. Weissleder,et al.  Mast cells are an essential hematopoietic component for polyp development , 2007, Proceedings of the National Academy of Sciences.

[73]  S. Holgate,et al.  Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[74]  P. Askenase Immune inflammatory responses to parasites: the role of basophils, mast cells and vasoactive amines. , 1977, The American journal of tropical medicine and hygiene.

[75]  P. Askenase,et al.  The effect of histamine, antihistamines, and a mast cell stabilizer on the growth of cloudman melanoma cells in DBA/2 mice. , 1983, The Journal of investigative dermatology.

[76]  F. Noonan,et al.  Dermal Mast Cells Determine Susceptibility to Ultraviolet B–induced Systemic Suppression of Contact Hypersensitivity Responses in Mice , 1998, The Journal of experimental medicine.

[77]  S. Galli,et al.  Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines , 1989, The Journal of experimental medicine.

[78]  J. Morrow,et al.  Evidence that histamine is the causative toxin of scombroid-fish poisoning. , 1991, The New England journal of medicine.

[79]  J. Drazen,et al.  Evaluation of the Substrate Specificity of Human Mast Cell Tryptase βI and Demonstration of Its Importance in Bacterial Infections of the Lung* , 2001, The Journal of Biological Chemistry.

[80]  R. Pawankar,et al.  Heterogeneity of mast cells and T cells in the nasal mucosa. , 1996, The Journal of allergy and clinical immunology.

[81]  J. Kinet,et al.  Complete structure and expression in transfected cells of high affinity IgE receptor , 1989, Nature.

[82]  John T. Chang,et al.  Inducible MHC Class II Expression by Mast Cells Supports Effector and Regulatory T Cell Activation 1 , 2009, The Journal of Immunology.

[83]  Y. Okayama,et al.  Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. , 2003, Blood.

[84]  E. Orr Presence and Distribution of Nervous System‐Associated Mast Cells That May Modulate Experimental Autoimmune Encephalomyelitis , 1988 .